BSX
Boston Scientific Corp
NYSE: BSX · HEALTHCARE · MEDICAL DEVICES
$57.61
+0.80% today
Updated 2026-04-30
Market cap
$85.62B
P/E ratio
24.10
P/S ratio
4.15x
EPS (TTM)
$2.39
Dividend yield
—
52W range
$56 – $110
Volume
16.0M
Boston Scientific Corp (BSX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $8.20B | $31.10B | $31.20B | $27.08B | $25.18B | $22.13B | $21.29B | $17.15B | $16.73B | $16.83B | $18.13B | $18.10B | $19.04B | $21.00B | $30.57B | $30.78B | $32.23B | $32.47B | $35.14B | $39.40B |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $2.63B | $4.90B | $5.92B | $5.45B | $4.06B | $3.62B | $3.10B | $3.02B | $3.17B | $3.39B | $3.47B | $3.24B | $3.82B | $4.00B | $4.70B | $6.69B | $6.32B | $5.76B | $6.51B | $6.92B |
| Total liabilities | $3.91B | $15.80B | $16.10B | $13.94B | $12.88B | $10.83B | $9.94B | $10.28B | $10.20B | $9.99B | $11.81B | $11.36B | $12.03B | $12.27B | $16.69B | $15.45B | $15.61B | $14.90B | $15.61B | $17.39B |
| Current liabilities | $1.48B | $2.63B | $3.25B | $3.21B | $3.02B | $2.61B | $1.81B | $1.77B | $1.82B | $2.25B | $2.43B | $3.59B | $5.65B | $5.26B | $4.87B | $3.68B | $4.27B | $3.80B | $4.93B | $6.40B |
| Long-term debt | $1.86B | $8.89B | $7.93B | $6.74B | $5.92B | $4.93B | $4.26B | $4.25B | $4.24B | $3.86B | $5.67B | $5.42B | $3.81B | $4.80B | $8.59B | $9.12B | $8.79B | $8.91B | $8.57B | $8.84B |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $3.41B | $-174.00M | $-693.00M | $-2.73B | $-3.76B | $-4.82B | $-4.38B | $-8.48B | $-8.57B | $-8.30B | $-8.93B | $-8.58B | $-8.39B | $-6.95B | $-2.25B | $-2.38B | $-1.39B | $-750.00M | $819.00M | $2.67B |
| Accounts receivable | $932.00M | $1.42B | $1.50B | $1.40B | $1.38B | $1.32B | $1.25B | $1.22B | $1.31B | $1.18B | $1.27B | $1.47B | $1.55B | $1.61B | $1.83B | $1.53B | $1.78B | $1.97B | $2.23B | $2.56B |
| Inventory | $418.00M | $749.00M | $725.00M | $853.00M | $920.00M | $894.00M | $931.00M | $884.00M | $897.00M | $946.00M | $1.02B | $955.00M | $1.08B | $1.17B | $1.58B | $1.35B | $1.61B | $1.87B | $2.48B | $2.81B |
| Goodwill | $1.94B | $14.63B | $15.10B | $12.42B | $12.40B | $10.19B | $9.76B | $5.97B | $5.69B | $5.90B | $6.47B | $6.68B | $7.00B | $7.91B | $10.18B | $9.95B | $11.99B | $12.92B | $14.39B | $17.09B |